The management of hereditary angioedema

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1983 English Publisher:Springer Science and Business Media LLCJournal:La Ricerca in Clinica e in Laboratorio, volume 13, pages 55-59 (issn: 0390-5748,

Copyright policy )

Authors: A, Agostoni;

doi: 10.1007/bf02904745

pmid: 6857097

The management of hereditary angioedema

- Summary
- Subjects
- Metrics

Abstract

Our experience in managing 120 cases of hereditary angioedema is reported. Forty-two severe episodes of mucous or subcutaneous edema were successfully managed using CI-INH concentrate. A prophylactic treatment was done with two classes of drugs: antifibrinolytic agents (tranexamic acid) and 17α-alkylated androgen derivatives.

Related Organizations

Ospedale San Paolo
Italy
University of Milan
Italy

Keywords

Tranexamic Acid, Danazol, Acute Disease, Humans, Complement C4, Angioedema, Complement C1 Inactivator Proteins, Stanozolol

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	2
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average